Company Search
CEO Interview
Drive With Dynacor Video Series
TSX_DNG on 2012-05-17 10:38Dynacor has released a new video series called the "Drive With Dynacor". http://youtu.be/seFbg2CXt6U
NAI Blog
My Top Junior Oil Stock in the Permian Basin “Tight” Oil Play Keith Schaefer on 2012-04-26 07:40:54Part 2: The Permian Basin – Cline Shale Resource Play
Company News - Company Data
TSO3 announces financial results for Q1 2012
Posted 2012-05-09 00:19NAI Editing
an innovator in sterilization technology for medical devices in healthcare settings, posted total revenues of $780,291 for the first quarter of 2012 ending March 31, for the sale of 3M™ Optreoz&TSO3 completes a $8.97 million bought deal private placement
Posted 2012-04-24 00:34NAI Editing
an innovator in sterilization technology for medical devices in healthcare settings, is pleased to announce the closing of a private placement on a firm underwritten basis for the purchase of 6,900,00TSO3 resubmits documents to proceed with US regulatory clearance
Posted 2012-04-19 23:59NAI Editing
an innovator in sterilization technology for medical devices in healthcare settings, announced today that it is resubmitting documentation to the United States (U.S.) regulatory authorities for the STSO3 Announces Full Exercise of Underwriters' Option to Purchase Additional Units
Posted 2012-04-05 01:26NAI Editing
,an innovator in sterilization technology for medical devices in healthcare settings, today announced that, in relation to the private placement of units on a bought deal basis (the "Offering") announTSO3 Announces $7.8 Million Bought Private Placement
Posted 2012-04-02 07:54NAI Editing
,an innovator in sterilization technology for medical devices in healthcare settings, is pleased to announce it has entered into an agreement with a syndicate of underwriters led by Desjardins CapitalTSO3 Discloses Fourth Quarter and Full Year 2011 Fiscal Results - Reports Best Results in 12-year History
Posted 2012-03-14 01:05NAI Editing
Highlights of 2011 events Commercial / OperationsTSO3 to File Additional Data Requested by the US Regulatory Agency
Posted 2012-03-12 01:31NAI Editing
, an innovator in sterilization technology for medical devices in healthcare settings, today announced that it will provide additional data to the US Regulatory Agency in support of obtaining 510(k) TSO3: Q3 Highest Revenue Generating Quarter in Company History
Posted 2011-11-02 01:05NAI Editing
-Highlights of Q3 2011 and activities of recent weeks:TSO3 Adopts Shareholder Rights Plan
Posted 2011-10-25 01:06NAI Editing
,an innovator in low temperature sterile reprocessing solutions for medical devices in healthcare settings, announced today that the Board of Directors of the Corporation has adopted a shareholder rigTSO3 provides an Update on Commercial Launch and Regulatory Activities - Customers Report High Satisfaction With New Sterilizer
Posted 2011-09-29 23:43NAI Editing
,an innovator in low temperature sterile reprocessing solutions for medical devices in healthcare settings, today outlined commercial progress in cleared markets, as well as gave details on the progra
Posted 2012-05-09 00:19
NAI Editingan innovator in sterilization technology for medical devices in healthcare settings, posted total revenues of $780,291 for the first quarter of 2012 ending March 31, for the sale of 3M™ Optreoz&TSO3 completes a $8.97 million bought deal private placement
Posted 2012-04-24 00:34
NAI Editingan innovator in sterilization technology for medical devices in healthcare settings, is pleased to announce the closing of a private placement on a firm underwritten basis for the purchase of 6,900,00TSO3 resubmits documents to proceed with US regulatory clearance
Posted 2012-04-19 23:59
NAI Editingan innovator in sterilization technology for medical devices in healthcare settings, announced today that it is resubmitting documentation to the United States (U.S.) regulatory authorities for the STSO3 Announces Full Exercise of Underwriters' Option to Purchase Additional Units
Posted 2012-04-05 01:26
NAI Editing,an innovator in sterilization technology for medical devices in healthcare settings, today announced that, in relation to the private placement of units on a bought deal basis (the "Offering") announTSO3 Announces $7.8 Million Bought Private Placement
Posted 2012-04-02 07:54
NAI Editing,an innovator in sterilization technology for medical devices in healthcare settings, is pleased to announce it has entered into an agreement with a syndicate of underwriters led by Desjardins CapitalTSO3 Discloses Fourth Quarter and Full Year 2011 Fiscal Results - Reports Best Results in 12-year History
Posted 2012-03-14 01:05
NAI EditingHighlights of 2011 events Commercial / OperationsTSO3 to File Additional Data Requested by the US Regulatory Agency
Posted 2012-03-12 01:31
NAI Editing, an innovator in sterilization technology for medical devices in healthcare settings, today announced that it will provide additional data to the US Regulatory Agency in support of obtaining 510(k) TSO3: Q3 Highest Revenue Generating Quarter in Company History
Posted 2011-11-02 01:05
NAI Editing-Highlights of Q3 2011 and activities of recent weeks:TSO3 Adopts Shareholder Rights Plan
Posted 2011-10-25 01:06
NAI Editing,an innovator in low temperature sterile reprocessing solutions for medical devices in healthcare settings, announced today that the Board of Directors of the Corporation has adopted a shareholder rigTSO3 provides an Update on Commercial Launch and Regulatory Activities - Customers Report High Satisfaction With New Sterilizer
Posted 2011-09-29 23:43
NAI Editing,an innovator in low temperature sterile reprocessing solutions for medical devices in healthcare settings, today outlined commercial progress in cleared markets, as well as gave details on the progra